United States: Recent FDA Initiatives To Support Development Of Individualized Cell And Gene Therapies And Rare Disease Therapies - Goodwin Procter LLP
![Mondaq](https://cdn.newsserve.net/p/mondaq.jpg)
Last month, FDA issued a Request for Information (RFI) in the Federal Register seeking information and comments from interested stakeholders regarding...
|
||||
You Might LikeRelated videos from verified sources
|